Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-001431.pdf 0001562180-17-001431.rtf 0001562180-17-001431.xls View HTML
March 31, 2017	CT ORDER	CT ORDER	9999999997-17-005213.pdf View HTML
March 6, 2017	SC 13G/A	An amendment to the SC 13G filing	0000790502-17-000002.pdf 0000790502-17-000002.rtf View HTML
March 6, 2017	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-17-003466.pdf 0001564590-17-003466.rtf 0001564590-17-003466.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 6, 2017	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-17-071604.pdf 0001193125-17-071604.rtf 0001193125-17-071604.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000880.pdf 0001562180-17-000880.rtf 0001562180-17-000880.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000878.pdf 0001562180-17-000878.rtf 0001562180-17-000878.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000881.pdf 0001562180-17-000881.rtf 0001562180-17-000881.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000879.pdf 0001562180-17-000879.rtf 0001562180-17-000879.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000882.pdf 0001562180-17-000882.rtf 0001562180-17-000882.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax